​

Baxter (BAX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BAX Stock Forecast

Baxter stock forecast is as follows: an average price target of $39.00 (represents a 34.95% upside from BAX’s last price of $28.90) and a rating consensus of 'Hold', based on 25 wall street analysts offering a 1-year stock forecast.

BAX Price Target

The average price target for Baxter (BAX) is $39.00 based on 1-year price targets from 25 Wall Street analysts in the past 3 months, with a price target range of $45.00 to $30.00. This represents a potential 34.95% upside from BAX's last price of $28.90.

BAX Analyst Ratings

Hold

According to 25 Wall Street analysts, Baxter's rating consensus is 'Hold'. The analyst rating breakdown for BAX stock is 0 'Strong Buy' (0.00%), 10 'Buy' (40.00%), 14 'Hold' (56.00%), 1 'Sell' (4.00%), and 0 'Strong Sell' (0.00%).

Baxter Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 04, 2024Travis SteedBank of America Securities$45.00$36.3223.90%55.71%
Aug 06, 2024Matthew TaylorJefferies$42.00$36.9213.76%45.33%
Jul 15, 2024Patrick WoodMorgan Stanley$30.00$35.32-15.06%3.81%
Jun 12, 2024David RomanGoldman Sachs$36.00$33.318.08%24.57%
May 03, 2024Danielle AntalffyUBS$40.00$36.918.37%38.41%
May 02, 2024Matthew TaylorJefferies$43.00$36.8916.56%48.79%
May 02, 2024Rick WiseStifel Nicolaus$44.00$36.7319.81%52.25%
Jul 31, 2023Matt MiksicBarclays$54.00$45.2619.32%86.85%
Jul 31, 2023Philippe HouchoisJefferies$85.00$47.0180.81%194.12%
Mar 27, 2023Joanne WuenschCitigroup$44.00$39.7110.80%52.25%
Apr 29, 2022Raymond James$85.00$70.3520.82%194.12%
Apr 29, 2022Wells Fargo$90.00$70.2028.20%211.42%
Mar 03, 2022Travis SteedBank of America Securities$100.00$85.1917.38%246.02%
Feb 18, 2022David LewisMorgan Stanley$105.00$82.3527.50%263.32%
Feb 13, 2022Amit HazanGoldman Sachs$91.00$85.915.92%214.88%
Jan 07, 2022Joanne WuenschCitigroup$101.00$87.1615.88%249.48%
Dec 17, 2021Robbie MarcusJ.P. Morgan$95.00$83.3613.96%228.72%
Dec 13, 2021Josh JenningsCowen & Co.$98.00$82.9318.17%239.10%
Sep 02, 2021Matthew O'BrienPiper Sandler$82.00$80.491.88%183.74%

The latest Baxter stock forecast, released on Oct 04, 2024 by Travis Steed from Bank of America Securities, set a price target of $45.00, which represents a 23.90% increase from the stock price at the time of the forecast ($36.32), and a 55.71% increase from BAX last price ($28.90).

Baxter Price Target by Period

1M3M12M
# Anlaysts-17
Avg Price Target-$45.00$40.00
Last Closing Price$28.90$28.90$28.90
Upside/Downside-100.00%55.71%38.41%

In the current month, the average price target of Baxter stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Baxter's last price of $28.90. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Sep 30, 2024Deutsche BankHoldHoldHold
Aug 06, 2024JefferiesHoldHoldHold
Jul 15, 2024Morgan StanleyEqual-WeightUnderweightDowngrade
Jun 12, 2024Goldman SachsNeutralNeutralHold
May 30, 2024Goldman SachsBuyNeutralInitialise
May 22, 2024CitigroupNeutralNeutralHold
May 10, 2024Cowen & Co.Sector WeightHoldDowngrade
May 03, 2024UBSNeutralNeutralHold
May 02, 2024JefferiesHoldHoldHold
Apr 03, 2024CitigroupNeutralNeutralHold
Feb 12, 2024BarclaysOverweightOverweightHold
Dec 12, 2023CitigroupNeutralNeutralHold
Dec 04, 2023Morgan StanleyEqual-WeightEqual-WeightHold
Jul 31, 2023BarclaysOverweightOverweightHold
Mar 27, 2023SVB LeerinkMarket PerformMarket PerformHold
Jan 05, 2023ScotiabankSector PerformInitialise
Jan 05, 2023Canaccord GenuityBuyInitialise
Jan 05, 2023Wolfe ResearchPeer PerformInitialise
Jan 05, 2023BenchmarkSpeculative BuyInitialise
Jan 05, 2023BMO CapitalOutperformInitialise
Jan 05, 2023B. Riley SecuritiesBuyInitialise
Jan 05, 2023Piper SandlerOverweightNeutralInitialise
Jan 05, 2023EF HuttonBuyHoldInitialise
Dec 19, 2022NeedhamBuyInitialise
Dec 19, 2022Goldman SachsBuyInitialise
Dec 19, 2022Loop Capital MarketsHoldInitialise
Dec 19, 2022JefferiesHoldBuyInitialise
Dec 19, 2022EF HuttonBuyInitialise
Dec 19, 2022William BlairOutperformInitialise
Dec 19, 2022BTIGBuyInitialise
Dec 19, 2022Keefe, Bruyette & WoodsMarket PerformInitialise
Dec 12, 2022SusquehannaNeutralInitialise
Dec 12, 2022Credit SuisseNeutralInitialise
Dec 12, 2022Piper SandlerOverweightInitialise
Dec 12, 2022JefferiesHoldInitialise
Dec 12, 2022Cowen & Co.Sector WeightInitialise
Oct 28, 2022Raymond JamesOutperformOutperformHold
Jun 30, 2022Bank of America SecuritiesBuyBuyHold
May 17, 2022CitigroupBuyBuyHold
Apr 29, 2022Raymond JamesOutperformOutperformHold
Apr 29, 2022Morgan StanleyOverweightOverweightHold
Apr 29, 2022Wells FargoOverweightOverweightHold
Feb 18, 2022Raymond JamesOutperformOutperformHold
Feb 18, 2022Morgan StanleyOverweightOverweightHold

Baxter's last stock rating was published by Deutsche Bank on Sep 30, 2024. The company gave BAX a "Hold" rating, the same as its previous rate.

Baxter Financial Forecast

Baxter Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue-------------$3.71B$3.71B$3.65B$3.89B$3.77B$3.75B$3.71B$3.51B$3.23B$3.10B$2.95B$3.18B$2.97B$2.72B$2.80B$3.04B$2.85B
Avg Forecast$3.06B$2.98B$3.01B$2.75B$2.95B$2.86B$2.85B$2.61B$2.67B$3.85B$3.75B$3.55B$3.81B$3.70B$3.79B$3.60B$3.77B$3.77B$3.88B$3.68B$3.30B$3.23B$3.11B$2.90B$3.12B$2.83B$2.87B$2.73B$3.04B$2.86B
High Forecast$3.13B$3.04B$3.07B$2.80B$3.01B$2.92B$2.91B$2.69B$2.70B$3.85B$3.75B$3.55B$3.82B$3.78B$3.87B$3.68B$3.85B$3.77B$3.88B$3.68B$3.30B$3.23B$3.11B$2.90B$3.12B$2.83B$2.87B$2.73B$3.04B$2.86B
Low Forecast$2.99B$2.91B$2.94B$2.68B$2.88B$2.79B$2.78B$2.55B$2.63B$3.85B$3.75B$3.55B$3.78B$3.67B$3.70B$3.52B$3.68B$3.77B$3.88B$3.68B$3.30B$3.23B$3.11B$2.90B$3.12B$2.83B$2.87B$2.73B$3.04B$2.86B
# Analysts2222111484347109988889999916811711
Surprise %-------------1.00%0.98%1.01%1.03%1.00%0.97%1.01%1.06%1.00%1.00%1.02%1.02%1.05%0.95%1.02%1.00%1.00%

Baxter's average Quarter revenue forecast for Dec 23 based on 7 analysts is $3.81B, with a low forecast of $3.78B, and a high forecast of $3.82B. BAX's average Quarter revenue forecast represents a 2.65% increase compared to the company's last Quarter revenue of $3.71B (Sep 23).

Baxter EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts2222111484347109988889999916811711
EBITDA-------------$-51.00M$-1.00M$187.00M$368.00M$265.00M$720.00M$534.00M$602.00M$709.00M$648.00M$603.00M$461.00M$663.00M$530.00M$605.00M$12.00M$690.00M
Avg Forecast$389.60M$378.79M$382.61M$349.28M$375.17M$363.18M$362.76M$332.02M$339.60M$489.27M$477.60M$567.49M$484.15M$470.26M$481.50M$515.90M$655.77M$438.92M$452.02M$469.00M$384.58M$376.05M$362.43M$500.95M$363.24M$330.11M$334.09M$520.97M$354.21M$333.53M
High Forecast$397.94M$386.89M$390.79M$356.75M$383.19M$370.94M$370.51M$342.16M$343.43M$489.48M$477.60M$680.99M$485.43M$480.20M$491.80M$619.08M$786.93M$438.92M$452.02M$562.80M$384.58M$376.05M$362.43M$601.14M$363.24M$330.11M$334.09M$625.17M$354.21M$333.53M
Low Forecast$380.32M$369.76M$373.49M$340.96M$366.22M$354.52M$354.11M$324.42M$334.50M$489.07M$477.60M$453.99M$480.33M$466.57M$470.03M$412.72M$524.62M$438.92M$452.02M$375.20M$384.58M$376.05M$362.43M$400.76M$363.24M$330.11M$334.09M$416.78M$354.21M$333.53M
Surprise %--------------0.11%-0.00%0.36%0.56%0.60%1.59%1.14%1.57%1.89%1.79%1.20%1.27%2.01%1.59%1.16%0.03%2.07%

9 analysts predict BAX's average Quarter EBITDA for Jun 23 to be $481.50M, with a high of $491.80M and a low of $470.03M. This is 157.49% upper than Baxter's previous annual EBITDA (Mar 23) of $187.00M.

Baxter Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts2222111484347109988889999916811711
Net Income-------------$2.51B$-141.00M$44.00M$181.00M$-2.93B$252.00M$71.00M$242.00M$450.00M$298.00M$298.00M$168.00M$356.00M$246.00M$331.00M$-23.00M$369.00M
Avg Forecast$399.36M$363.52M$332.80M$286.72M$359.60M$338.14M$318.07M$260.97M$264.82M$397.63M$339.15M$71.95M$442.56M$341.54M$306.98M$65.41M$259.26M$415.73M$445.49M$59.46M$523.02M$478.25M$381.95M$247.57M$386.31M$371.30M$359.25M$285.03M$452.57M$426.96M
High Forecast$410.47M$373.63M$342.05M$294.69M$369.60M$347.54M$326.92M$281.05M$272.18M$398.31M$339.26M$86.34M$447.70M$396.79M$315.52M$78.49M$311.11M$415.73M$445.49M$71.36M$523.02M$478.25M$381.95M$297.08M$386.31M$371.30M$359.25M$342.03M$452.57M$426.96M
Low Forecast$386.98M$352.26M$322.49M$277.84M$348.46M$327.66M$308.22M$250.94M$259.72M$396.96M$339.05M$57.56M$437.41M$331.50M$297.47M$52.33M$207.41M$415.73M$445.49M$47.57M$523.02M$478.25M$381.95M$198.06M$386.31M$371.30M$359.25M$228.02M$452.57M$426.96M
Surprise %-------------7.34%-0.46%0.67%0.70%-7.06%0.57%1.19%0.46%0.94%0.78%1.20%0.43%0.96%0.68%1.16%-0.05%0.86%

Baxter's average Quarter net income forecast for Dec 23 is $442.56M, with a range of $437.41M to $447.70M. BAX's average Quarter net income forecast represents a -82.35% decrease compared to the company's last Quarter net income of $2.51B (Sep 23).

Baxter SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts2222111484347109988889999916811711
SG&A-------------$1.00B$964.00M$1.01B$912.00M$942.00M$976.00M$1.05B$896.00M$680.00M$678.00M$627.00M$696.00M$601.00M$590.00M$628.00M$1.42B$627.00M
Avg Forecast$764.76M$743.54M$751.03M$685.61M$736.42M$712.89M$712.06M$651.73M$666.62M$960.41M$937.49M$1.07B$950.35M$923.09M$945.15M$969.15M$976.03M$938.10M$966.09M$881.05M$821.95M$803.71M$774.62M$520.89M$776.34M$705.55M$714.04M$540.78M$757.04M$712.84M
High Forecast$781.12M$759.44M$767.09M$700.28M$752.17M$728.13M$727.29M$671.63M$674.14M$960.80M$937.49M$1.28B$952.85M$942.60M$965.37M$1.16B$1.17B$938.10M$966.09M$1.06B$821.95M$803.71M$774.62M$625.07M$776.34M$705.55M$714.04M$648.93M$757.04M$712.84M
Low Forecast$746.53M$725.81M$733.13M$669.27M$718.87M$695.89M$695.09M$636.81M$656.59M$960.01M$937.49M$852.86M$942.85M$915.84M$922.63M$775.32M$780.82M$938.10M$966.09M$704.84M$821.95M$803.71M$774.62M$416.71M$776.34M$705.55M$714.04M$432.62M$757.04M$712.84M
Surprise %-------------1.09%1.02%1.04%0.93%1.00%1.01%1.19%1.09%0.85%0.88%1.20%0.90%0.85%0.83%1.16%1.88%0.88%

Baxter's average Quarter SG&A projection for Dec 23 is $950.35M, based on 7 Wall Street analysts, with a range of $942.85M to $952.85M. The forecast indicates a -5.15% fall compared to BAX last annual SG&A of $1.00B (Sep 23).

Baxter EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts2222111484347109988889999916811711
EPS-------------$4.95$-0.28$0.09$0.36$-5.82$0.50$0.14$0.48$0.90$0.59$0.59$0.33$0.70$0.48$0.65$-0.05$0.72
Avg Forecast$0.78$0.71$0.65$0.56$0.70$0.66$0.62$0.51$0.52$0.78$0.66$0.61$0.86$0.67$0.60$0.49$0.94$0.82$0.87$0.80$1.03$0.94$0.75$0.65$0.76$0.73$0.70$0.73$0.89$0.84
High Forecast$0.80$0.73$0.67$0.58$0.72$0.68$0.64$0.55$0.53$0.78$0.66$0.61$0.87$0.77$0.62$0.51$0.97$0.82$0.87$0.80$1.03$0.94$0.75$0.65$0.76$0.73$0.70$0.73$0.89$0.84
Low Forecast$0.76$0.69$0.63$0.54$0.68$0.64$0.60$0.49$0.51$0.78$0.66$0.61$0.85$0.65$0.58$0.48$0.91$0.82$0.87$0.80$1.03$0.94$0.75$0.65$0.76$0.73$0.70$0.73$0.89$0.84
Surprise %-------------7.42%-0.47%0.18%0.38%-7.14%0.57%0.17%0.47%0.96%0.79%0.91%0.44%0.96%0.68%0.89%-0.05%0.86%

According to 7 Wall Street analysts, Baxter's projected average Quarter EPS for Dec 23 is $0.86, with a low estimate of $0.85 and a high estimate of $0.87. This represents a -82.54% decrease compared to BAX previous annual EPS of $4.95 (Sep 23).

Baxter Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
TFXTeleflex$178.28$254.5042.75%Buy
BAXBaxter$29.64$39.0031.58%Hold
BDXBecton, Dickinson and Company$225.64$278.7523.54%Buy
COOCooper Companies$94.49$115.0021.71%Buy
ALCAlcon$85.54$104.0021.58%Buy
ICUIICU Medical$157.17$190.5021.21%Buy
WSTWest Pharmaceutical Services$334.26$393.0017.57%Buy
EMBCEmbecta$19.82$23.0016.04%Buy
MMSIMerit Medical Systems$99.00$108.839.93%Buy
NVSTEnvista$19.24$20.295.46%Hold
HOLXHologic$72.26$74.202.68%Buy
RMDResMed$242.62$233.50-3.76%Hold

BAX Forecast FAQ

Is Baxter a good buy?

No, according to 25 Wall Street analysts, Baxter (BAX) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 10 'Buy' recommendations, accounting for 40.00% of BAX's total ratings.

What is BAX's price target?

Baxter (BAX) average price target is $39 with a range of $30 to $45, implying a 34.95% from its last price of $28.9. The data is based on 25 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Baxter stock go up soon?

According to Wall Street analysts' prediction for BAX stock, the company can go up by 34.95% (from the last price of $28.9 to the average price target of $39), up by 55.71% based on the highest stock price target, and up by 3.81% based on the lowest stock price target.

Can Baxter stock reach $40?

BAX's highest twelve months analyst stock price target of $45 supports the claim that Baxter can reach $40 in the near future.

What are Baxter's analysts' financial forecasts?

Baxter's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $11.27B (high $11.53B, low $11B), average EBITDA is $1.43B (high $1.47B, low $1.4B), average net income is $1.28B (high $1.33B, low $1.24B), average SG&A $2.81B (high $2.88B, low $2.75B), and average EPS is $2.49 (high $2.59, low $2.41). BAX's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $11.8B (high $12.05B, low $11.51B), average EBITDA is $1.5B (high $1.53B, low $1.46B), average net income is $1.38B (high $1.42B, low $1.34B), average SG&A $2.94B (high $3.01B, low $2.87B), and average EPS is $2.7 (high $2.78, low $2.62).

Did the BAX's actual financial results beat the analysts' financial forecasts?

Based on Baxter's last annual report (Dec 2022), the company's revenue was $15.11B, beating the average analysts forecast of $15.09B by 0.16%. Apple's EBITDA was $854M, missing the average prediction of $2.02B by -57.63%. The company's net income was $-2.421B, missing the average estimation of $1.18B by -305.18%. Apple's SG&A was $3.89B, beating the average forecast of $3.76B by 3.34%. Lastly, the company's EPS was $-4.8, missing the average prediction of $3.43 by -239.97%. In terms of the last quarterly report (Sep 2023), Baxter's revenue was $3.71B, beating the average analysts' forecast of $3.7B by 0.29%. The company's EBITDA was $-51M, missing the average prediction of $470.26M by -110.84%. Baxter's net income was $2.51B, beating the average estimation of $341.54M by 634.31%. The company's SG&A was $1B, beating the average forecast of $923.09M by 8.55%. Lastly, the company's EPS was $4.95, beating the average prediction of $0.667 by 642.04%